Skip to main content

Table 1 Demography and clinical characteristics of early age acute leukaemia subtypes, Brazil, 2000-2010

From: RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures

 

Total, n (%)

ALL (%) (n = 150)

AML (%) (n = 85)

p

Age (months)

    

≤12

120 (51.1)

82 (54.7)

38 (44.7)

0.14

13-24

115 (48.9)

68 (45.3)

47 (55.3)

 

Gender

    

Male

131 (55.7)

78 (52.0)

53 (62.4)

0.12

Female

104 (44.3)

72 (48.0)

32 (37.6)

 

Skin colour

    

White

139 (59.9)

92 (61.7)

47 (56.6)

0.44

Non-White

93 (40.1)

57 (38.3)

36 (43.4)

 

WBC (x10 9 /L)

    

≤50

106 (46.5)

59 (40.4)

47 (57.3)

0.01

>50

122 (53.5)

87 (59.6)

35 (42.7)

 

Chromosomal alterations

    

MLL r

102 (77.3)

73 (78.5)

29 (74.4)

0.006

ETV6-RUNX1

7 (5.3)

7 (7.5)

0 (0.0)

 

Hyperdiploidy

6 (4.5)

6 (6.5)

0 (0.0)

 

Others

17 (12.9)

7 (7.5)a

10 (25.6)b

 

RAS c

    

Wild-type

175 (74.5)

105 (70.0)

70 (82.4)

0.03

Mutated

60 (25.5)

45 (30.0)

15 (17.6)

 

BRAF

    

Wild-type

124 (99.2)

61 (100.0)

63 (98.4)

1.00

Mutated

1 (0.8)

0 (0.0)

1 (1.6)

 

FLT3

    

Wild-type

148 (93.1)

88 (91.7)

60 (95.2)

0.52

Mutated

11 (6.9)

8 (8.3)

3 (4.8)

 

NQO1 (rs1800566) d

    

CC

97 (54.2)

67 (53.6)

30 (55.6)

0.91

CT

70 (39.1)

50 (40.0)

20 (37.0)

 

TT

12 (6.7)

8 (6.4)

4 (7.4)

 
  1. aFour pre-B ALL cases presenting the fusion transcript TCF3-PBX1, one pre-B ALL case presenting the cytogenetics t(2;14)(p10;q23), one pre-B ALL case presenting the cytogenetics t(5;15)(q12;q13) and one common ALL case presenting complex karyotype. bOne M4-AML presenting RUNX1-RUNX1T1 fusion transcript. Five M4-AML cases presenting CBFβ-MYH11 fusion transcript. One M3-AML presenting PML-RARa fusion transcript. One M0-AML, one M7-AML case and one AML case not otherwise specified presenting complex karyotype. AML subtypes according to FAB classification; cMutations in either KRAS or NRAS. dGenotype frequencies of NQO1 polymorphism. ALL: acute lymphoblastic leukaemia; AML: acute myeloid leukaemia; n: number of cases; WBC: white blood cell; MLL r: rearranged MLL.